Marco Daoura Attends HLTH 2021
Marco Daoura, Principal (Strategic Consulting, Medical Devices, Digital Health and HealthIT), will attend HLTH 2021 on October 17 – 20 at the Boston Convention & Exhibition Center. His attendance at …
News
Dr. Robert Huebner Speaks at BioKansas Community Forum
LBG is pleased to announce that Dr. Bob Huebner, Principal Consultant, will participate in a panel at BioKansas’ Community Forum entitled “Accelerating Biologics: The Market Landscape and Engineering Advancements” on …
BioProcess Insider State of the Industry
LBG would like to congratulate Dr. Josh Speidel, who was invited to participate in the BioProcess Insider State of the Industry webcast on September 15! Chosen for his expertise, Dr. …
Latham BioPharm Group Article Wins BPI Readers’ Choice Award!
“Each year BioProcess International publishes over 150 technical and scientific articles focusing on the latest science, technologies, and techniques supporting biopharmaceutical research, development, and manufacturing.” BioProcess International, Your Choices for BPI’s Best …
Pandemic Preparedness and Response Panel
Sponsored by Center for Entrepreneurship, in partnership with the College of Arts and Sciences Department of Biology, Corporate Engagement Office, and TechGROWTH Ohio. November 18, 2020 Robert Huebner, a Principal …
Life Sciences Fueling Purposeful Innovation
Sponsored by Independence Blue Cross & B. PHL Innovation Fest Presented by Venture Café Philadelphia LBG’s Gervan Williams joined a diverse panel of experts to discuss emerging opportunities for innovators, investors, …
Determining disease severity in patients with COVID-19
Timothy Alcorn co-authored a paper published by Lab on a Chip titled, “Clinical decision support tool and rapid point-of-care platform for determining disease severity in patients with COVID-19†”. Dr. Alcorn …
“Crash Global Effort Underway to Increase Coronavirus Testing”
“There’s (a) fine balance between getting the test out there fast and making sure the test is accurate,” says Dr. Tim Alcorn, Director of Medical Devices and Diagnostics at Latham …
Latham BioPharm Group is thrilled to announce the addition of three new team members
LBG is thrilled to announce the addition of Dr. Robert Casillas, Dr. Thijs Beuming and Dr. Darrel J. Rezac to our Team—each of whom brings unique expertise that widens the …
Watch now! Roundtable Discussion: Cell and Gene Therapies — Keep the Work In-House, or Use a Third Party?
LBG’s Dr. Joseph Rininger, as an industry leader in Cell & Gene Therapies, was invited to participate in a roundtable discussion at BIO International 2019 on this topic. Questions posed to the panel by BioProcess Insider editor Dan …
